RxDoctor Payments Data

Lindsay Schweikarth

Surgical · Albany, NYNPI 1396042081

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $304,760 of the $324,231 with a category attached, or 94.0%. AbbVie accounts for 99.9% of it on its own, with 2 other manufacturers making up the rest. Among surgical clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$324,231in general payments, 2019–2025

Across 328 payments — averaging $988.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$324K
  • Revance Therapeutics, Inc.$413
  • Galderma Laboratories, L.p.$25

What the payments were for

  • Speaking & faculty fees$304,76094%
  • Travel & lodging$15,9415%
  • Food & beverage$3,5311%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)312$323,793
Revance Therapeutics, Inc.14$413
Galderma Laboratories, L.p.2$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$324,231 in reported general payments places this provider in the 95th percentile of 1,544 surgical providers in New York.

See all surgical providers in New York →

Other surgical in Albany

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →